ArticleAmerican journal of cancer research2025

Short- and long-term efficacy of olaparib combined with chemotherapy in advanced triple-negative breast cancer.

Wanfu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.